Hoth Therapeutics Stock Today
| HOTH Stock | USD 1.23 0.04 3.36% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Hoth Therapeutics is trading at 1.23 as of the 2nd of May 2024. This is a 3.36 percent up since the beginning of the trading day. The stock's open price was 1.19. Hoth Therapeutics has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Hoth Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of March 2024 and ending today, the 2nd of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 15th of February 2019 | Category Healthcare | Classification Health Care |
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. Hoth Therapeutics, Inc. was incorporated in 2017 and is headquartered in New York, New York. Hoth Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 4.89 M outstanding shares of which 146.58 K shares are currently shorted by private and institutional investors with about 0.12 trading days to cover. More on Hoth Therapeutics
Moving against Hoth Stock
| 0.47 | GCTK | GlucoTrack | PairCorr |
| 0.44 | MPW | Medical Properties Trust Earnings Call This Week | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Hoth Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Hoth Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Hoth Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Robb Knie | |||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Hoth Therapeutics report their recommendations after researching Hoth Therapeutics' financial statements, talking to executives and customers, or listening in on Hoth Therapeutics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Hoth Therapeutics. The Hoth consensus assessment is calculated by taking the average forecast from all of the analysts covering Hoth Therapeutics. | ||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key indicators related to Hoth Therapeutics' liquidity, profitability, solvency, and operating efficiency, Hoth Therapeutics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in June. Financial strength of Hoth Therapeutics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||
Hoth Therapeutics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Hoth Therapeutics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Hoth Therapeutics' financial leverage. It provides some insight into what part of Hoth Therapeutics' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||
Hoth Therapeutics (HOTH) is traded on NASDAQ Exchange in USA. It is located in 1 Rockefeller Plaza, New York, NY, United States, 10020 and employs 2 people. Hoth Therapeutics is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Hoth Therapeutics's market, we take the total number of its shares issued and multiply it by Hoth Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Hoth Therapeutics conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 4.89 M outstanding shares of which 146.58 K shares are currently shorted by private and institutional investors with about 0.12 trading days to cover.
Hoth Therapeutics currently holds about 11.62 M in cash with (8.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Hoth Therapeutics Probability Of Bankruptcy
Ownership AllocationRoughly 92.0 (percent) of Hoth Therapeutics outstanding shares are held by general public with 1.4 % owned by insiders and only 6.28 pct. by outside corporations.
Check Hoth Ownership Details
Hoth Stock Price Odds Analysis
Coming from a normal probability distribution, the odds of Hoth Therapeutics jumping above the current price in 90 days from now is about 76.65%. The Hoth Therapeutics probability density function shows the probability of Hoth Therapeutics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.1736. This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Hoth Therapeutics will likely underperform. Additionally, hoth Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Hoth Therapeutics to move above the current price in 90 days from now is about 76.65 (This Hoth Therapeutics probability density function shows the probability of Hoth Stock to fall within a particular range of prices over 90 days) .
Hoth Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Hoth Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Hoth Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Hoth Therapeutics' value.| Instituion | Recorded On | Shares | |
| Integrated Wealth Concepts Llc | 2023-09-30 | 0.0 | |
| Citadel Advisors Llc | 2023-09-30 | 0.0 | |
| Virtu Financial Llc | 2023-12-31 | 0.0 | |
| Two Sigma Securities, Llc | 2023-12-31 | 0.0 | |
| Vanguard Group Inc | 2023-12-31 | 38.8 K | |
| Geode Capital Management, Llc | 2023-12-31 | 23.5 K | |
| Ubs Group Ag | 2023-12-31 | 8.4 K | |
| Jpmorgan Chase & Co | 2023-12-31 | 6.3 K | |
| Tower Research Capital Llc | 2023-12-31 | 1.6 K | |
| Royal Bank Of Canada | 2023-12-31 | 240 | |
| Wells Fargo & Co | 2023-12-31 | 30.0 |
Hoth Therapeutics Historical Income Statement
Hoth Therapeutics Income Statement is one of the three primary financial statements used for reporting Hoth's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Hoth Therapeutics revenue and expense. Hoth Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Hoth Therapeutics' Total Operating Expenses is increasing as compared to previous years. View More FundamentalsHoth Stock Against Markets
Picking the right benchmark for Hoth Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Hoth Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Hoth Therapeutics is critical whether you are bullish or bearish towards Hoth Therapeutics at a given time. Please also check how Hoth Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Hoth Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
Hoth Therapeutics Corporate Management
Elected by the shareholders, the Hoth Therapeutics' board of directors comprises two types of representatives: Hoth Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hoth. The board's role is to monitor Hoth Therapeutics' management team and ensure that shareholders' interests are well served. Hoth Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hoth Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jane Springer | VP Operations | Profile | |
| Hayley Springer | Executive Operations | Profile | |
| Stefanie Johns | Chief Officer | Profile | |
| David Briones | Chief Officer | Profile |
How to buy Hoth Stock?
Before investing in Hoth Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Hoth Therapeutics. To buy Hoth Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Hoth Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Hoth Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Hoth Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Hoth Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Hoth Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Hoth Stock please use our How to Invest in Hoth Therapeutics guide.
Already Invested in Hoth Therapeutics?
The danger of trading Hoth Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Hoth Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Hoth Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Hoth Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Hoth Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Hoth Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Hoth Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Hoth Therapeutics Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hoth Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more detail on how to invest in Hoth Stock please use our How to Invest in Hoth Therapeutics guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Hoth Stock analysis
When running Hoth Therapeutics' price analysis, check to measure Hoth Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hoth Therapeutics is operating at the current time. Most of Hoth Therapeutics' value examination focuses on studying past and present price action to predict the probability of Hoth Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hoth Therapeutics' price. Additionally, you may evaluate how the addition of Hoth Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Hoth Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hoth Therapeutics. If investors know Hoth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hoth Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.30) | Return On Assets (0.59) | Return On Equity (1.13) |
The market value of Hoth Therapeutics is measured differently than its book value, which is the value of Hoth that is recorded on the company's balance sheet. Investors also form their own opinion of Hoth Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Hoth Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hoth Therapeutics' market value can be influenced by many factors that don't directly affect Hoth Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hoth Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Hoth Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hoth Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.